Origo Biopharma

Origo Biopharma is a Spanish pharmaceutical company founded in 2017 by entrepreneurs with extensive experience in drug discovery and development. Our expertise ranges from the early stages of medicinal chemistry to the successful execution of late-stage clinical trials, ultimately leading to the registration of novel drug products. We focus on researching and developing small molecules to address health disorders associated with TGF-β signaling dysfunction, including fibrosis and cancer.